Stefan Flasche

Active 1992–2025

99
Papers
20,770
Citations
49
h-index
91
i10-index

Citations

Citations per year for Stefan Flasche1990: 1 citations1992: 1 citations1997: 2 citations1998: 1 citations2000: 1 citations2002: 1 citations2004: 5 citations2005: 1 citations2007: 2 citations2009: 1 citations2010: 8 citations2011: 16 citations2012: 26 citations2013: 10 citations2014: 18 citations2015: 24 citations2016: 34 citations2017: 38 citations2018: 32 citations2019: 170 citations2020: 2,499 citations2021: 2,285 citations2022: 904 citations2023: 433 citations2024: 488 citations2025: 232 citations2026: 17 citations1991: no citations, so this year is not shown1993–1996: no citations, so these years are not shown1999: no citations, so this year is not shown2001: no citations, so this year is not shown2003: no citations, so this year is not shown2006: no citations, so this year is not shown2008: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,970 citing papers, 17.3% of this breakdownUnited Kingdom: 1,403 citing papers, 12.4% of this breakdownChina: 745 citing papers, 6.6% of this breakdownItaly: 406 citing papers, 3.6% of this breakdownAustralia: 389 citing papers, 3.4% of this breakdownIndia: 356 citing papers, 3.1% of this breakdownGermany: 340 citing papers, 3% of this breakdownCanada: 324 citing papers, 2.9% of this breakdownFrance: 323 citing papers, 2.8% of this breakdownSwitzerland: 311 citing papers, 2.7% of this breakdownSpain: 222 citing papers, 2% of this breakdownNetherlands: 207 citing papers, 1.8% of this breakdown
0%17.3%Other 38.4%

Fields

  • Medicine39.8%
  • Mathematics39.4%
  • Computer Science5%
  • Social Sciences3.9%
  • Psychology2.8%
  • Health Professions1.8%
  • Other7.3%

Topics

  • COVID-19 epidemiological studies18%
  • SARS-CoV-2 and COVID-19 Research8.5%
  • COVID-19 Clinical Research Studies5.1%
  • Viral Infections and Outbreaks Research3.5%
  • COVID-19 Pandemic Impacts3.3%
  • COVID-19 and Mental Health2.9%
  • Other58.7%

Coauthors

All papers

Open in search
  1. Age-dependent effects in the transmission and control of COVID-19 epidemics

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2020 cited by 1,860

  2. Early dynamics of transmission and control of COVID-19: a mathematical modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2020 cited by 2,664

  3. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kiesha Prem, Stefan Flasche, Carl A. B. Pearson, Rein M G J Houben, Emily Nightingale, Akira Endo, Damien C. Tully, Yang Liu, Julian Villabona-Arenas, Kathleen O’Reilly, Sebastian Funk, Rosalind M. Eggo, Mark Jit, Eleanor M. Rees, Joel Hellewell, Samuel Clifford, Christopher I Jarvis, Sam Abbott, Megan Auzenbergs, Nicholas G. Davies, David Simons - The Lancet Infectious Diseases 2020 cited by 958

  4. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Public Health 2020 cited by 2,315

  5. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Global Health 2020 cited by 2,826

  6. Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hamish P Gibbs, Lloyd A C Chapman, Katherine E. Atkins, David Hodgson, Rosanna C Barnard, Timothy W Russell, Petra Klepac, Yalda Jafari, Rosalind M Eggo, Paul Mee, Matthew Quaife, Akira Endo, Sebastian Funk, Stéphane Hué, Adam J Kucharski, W John Edmunds, Kathleen O'Reilly, Rachael Pung, C Julian Villabona-Arenas, Amy Gimma, Kaja Abbas, Kiesha Prem, Gwenan M Knight, Fiona Yueqian Sun, William Waites, James D Munday, Mihaly Koltai, Frank G Sandmann, Damien C Tully - The Lancet Infectious Diseases 2022 cited by 155

  7. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Graham F. Medley, Gwen Knight, James D Munday, Adam J. Kucharski, Carl A. B. Pearson, Petra Klepac, Kiesha Prem, Rein M G J Houben, Akira Endo, Stefan Flasche, Nicholas G. Davies, Charlie Diamond, Kevin van Zandvoort, Sebastian Funk, Megan Auzenbergs, Eleanor M. Rees, Damien C. Tully, Jon C. Emery, Billy J. Quilty, Sam Abbott, Christian Julián Villabona‐Arenas, Stéphane Hué, Joel Hellewell, Amy Gimma, Christopher I Jarvis - The Lancet Global Health 2020 cited by 1,231

  8. Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination

    Authors: , , , , , , , - The Lancet Regional Health - Europe 2024 cited by 66

  9. Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine

    Authors: , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2018 cited by 169

  10. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James D Munday, Alicia Roselló, Megan Auzenbergs, Gwen Knight, Rein M G J Houben, Yang Liu - The Lancet Public Health 2020 cited by 975

  11. Using a real-world network to model localized COVID-19 control strategies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rein M G J Houben, Gwenan M. Knight, Sam Abbott, Fiona Yueqian Sun, Rachel Lowe, Damien C. Tully, Simon R. Procter, Christopher I Jarvis, Akira Endo, Kathleen O’Reilly, Jon C. Emery, Thibaut Jombart, Alicia Roselló, Arminder Deol, Matthew Quaife, Stéphane Hué, Yang Liu, Rosalind M. Eggo, Carl A. B. Pearson, Adam J. Kucharski, Lewis G. Spurgin - Nature Medicine 2020 cited by 276

  12. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models

    Authors: , , , , , , , , , , , , , , , - The Lancet 2015 cited by 246

  13. Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jack Williams, Damien C. Tully, Stefan Flasche, Sophie Meakin, Kevin van Zandvoort, Fiona Yueqian Sun, Mark Jit, Petra Klepac, Matthew Quaife, Rosalind M. Eggo, Frank Sandmann, Akira Endo, Kiesha Prem, Sam Abbott, Rosanna C. Barnard, Yung-Wai D Chan, Megan Auzenbergs, Amy Gimma, Christian Julián Villabona‐Arenas, Nicholas G. Davies - The Lancet Public Health 2021 cited by 240

  14. Estimating the time-varying reproduction number of SARS-CoV-2 using national and subnational case counts

    Authors: , , , , , , , , , , , , , , , , , , , , , - Wellcome Open Research 2020 cited by 286

  15. The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study

    Authors: , , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2016 cited by 235

  16. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlie Diamond, Timothy Russell, Graham F. Medley, Stefan Flasche, Katherine E. Atkins, Kiesha Prem, David Simons, Megan Auzenbergs, Damien C. Tully, Christopher I Jarvis, Kevin van Zandvoort, Sam Abbott, Carl A. B. Pearson, Thibaut Jombart, Sophie Meakin, Anna M. Foss, Adam J. Kucharski, Billy J. Quilty, Hamish Gibbs, Samuel Clifford, Petra Klepac - The Lancet Infectious Diseases 2021 cited by 193

  17. Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis

    Authors: , , , , , , - The Lancet Global Health 2018 cited by 121

  18. Determinants of RSV epidemiology following suppression through pandemic contact restrictions

    Authors: , , , , , , - Epidemics 2022 cited by 52

  19. Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa

    Authors: , , , , , , , , , , , , , - BMC Medicine 2023 cited by 31

  20. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yang Liu, Akira Endo, Arminder Deol, Adam J. Kucharski, Sam Abbott, Christopher I Jarvis, Kathleen O’Reilly, Thibaut Jombart, Amy Gimma, Nikos I Bosse, Kiesha Prem, Stéphane Hué, Nicholas G. Davies, Rosalind M. Eggo, Samuel Clifford, Graham F. Medley - The Lancet Global Health 2020 cited by 373

  21. Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James W. Rudge, Katherine E. Atkins, Megan Auzenbergs, Stefan Flasche, Rein M G J Houben, Billy J. Quilty, Petra Klepac, Matthew Quaife, Sebastian Funk, Quentin J. Leclerc, Jon C. Emery, Mark Jit, David Simons, Nikos I Bosse, Simon R. Procter, Fiona Yueqian Sun, Samuel Clifford, Katharine Sherratt, Alicia Roselló, Nicholas G. Davies, Oliver J. Brady, Damien C. Tully, Georgia R. Gore‐Langton - BMC Medicine 2020 cited by 217

  22. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials

    Authors: , , , , , , , - The Lancet Infectious Diseases 2019 cited by 124

  23. Within-host dynamics shape antibiotic resistance in commensal bacteria

    Authors: , , , - Nature Ecology & Evolution 2019 cited by 109

  24. Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales

    Authors: , , , , , - Vaccine 2022 cited by 32